Global Fluorodeoxyglucose Market Research Report 2023

Publication ID:

PB503241918

Publication Date:

March 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Fluorodeoxyglucose is a radiopharmaceutical, specifically a radiotracer, used in the medical imaging modality positron emission tomography (PET)
Highlights
The global Fluorodeoxyglucose market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Fluorodeoxyglucose is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Fluorodeoxyglucose is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Fluorodeoxyglucose include Md Anderson Cancer Center, Shertech Laboratories, LLC, Ucsf Radiopharmaceutical Facility, Memorial Sloan-kettering Cancer Center, Hot Shots Nuclear Medicine Llc, Pharmalogic Holdings Corp, Nukemed Inc Dba Spectronrx, Precision Nuclear Llc and The Methodist Hosp Research Institute, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fluorodeoxyglucose, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorodeoxyglucose.
The Fluorodeoxyglucose market size, estimations, and forecasts are provided in terms of sales volume (Dose) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Fluorodeoxyglucose market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluorodeoxyglucose manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Md Anderson Cancer Center
Shertech Laboratories, LLC
Ucsf Radiopharmaceutical Facility
Memorial Sloan-kettering Cancer Center
Hot Shots Nuclear Medicine Llc
Pharmalogic Holdings Corp
Nukemed Inc Dba Spectronrx
Precision Nuclear Llc
The Methodist Hosp Research Institute
3d Imaging Drug Design And Development Llc
Segment by Type
18F-2
18F
Segment by Application
Medical Imaging
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fluorodeoxyglucose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fluorodeoxyglucose in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Fluorodeoxyglucose Market Overview
1.1 Product Overview and Scope of Fluorodeoxyglucose
1.2 Fluorodeoxyglucose Segment by Type
1.2.1 Global Fluorodeoxyglucose Market Value Comparison by Type (2023-2029)
1.2.2 18F-2
1.2.3 18F
1.3 Fluorodeoxyglucose Segment by Application
1.3.1 Global Fluorodeoxyglucose Market Value by Application: (2023-2029)
1.3.2 Medical Imaging
1.3.3 Others
1.4 Global Fluorodeoxyglucose Market Size Estimates and Forecasts
1.4.1 Global Fluorodeoxyglucose Revenue 2018-2029
1.4.2 Global Fluorodeoxyglucose Sales 2018-2029
1.4.3 Global Fluorodeoxyglucose Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Fluorodeoxyglucose Market Competition by Manufacturers
2.1 Global Fluorodeoxyglucose Sales Market Share by Manufacturers (2018-2023)
2.2 Global Fluorodeoxyglucose Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Fluorodeoxyglucose Average Price by Manufacturers (2018-2023)
2.4 Global Fluorodeoxyglucose Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Fluorodeoxyglucose, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fluorodeoxyglucose, Product Type & Application
2.7 Fluorodeoxyglucose Market Competitive Situation and Trends
2.7.1 Fluorodeoxyglucose Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fluorodeoxyglucose Players Market Share by Revenue
2.7.3 Global Fluorodeoxyglucose Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fluorodeoxyglucose Retrospective Market Scenario by Region
3.1 Global Fluorodeoxyglucose Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Fluorodeoxyglucose Global Fluorodeoxyglucose Sales by Region: 2018-2029
3.2.1 Global Fluorodeoxyglucose Sales by Region: 2018-2023
3.2.2 Global Fluorodeoxyglucose Sales by Region: 2024-2029
3.3 Global Fluorodeoxyglucose Global Fluorodeoxyglucose Revenue by Region: 2018-2029
3.3.1 Global Fluorodeoxyglucose Revenue by Region: 2018-2023
3.3.2 Global Fluorodeoxyglucose Revenue by Region: 2024-2029
3.4 North America Fluorodeoxyglucose Market Facts & Figures by Country
3.4.1 North America Fluorodeoxyglucose Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Fluorodeoxyglucose Sales by Country (2018-2029)
3.4.3 North America Fluorodeoxyglucose Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fluorodeoxyglucose Market Facts & Figures by Country
3.5.1 Europe Fluorodeoxyglucose Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Fluorodeoxyglucose Sales by Country (2018-2029)
3.5.3 Europe Fluorodeoxyglucose Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fluorodeoxyglucose Market Facts & Figures by Country
3.6.1 Asia Pacific Fluorodeoxyglucose Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Fluorodeoxyglucose Sales by Country (2018-2029)
3.6.3 Asia Pacific Fluorodeoxyglucose Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fluorodeoxyglucose Market Facts & Figures by Country
3.7.1 Latin America Fluorodeoxyglucose Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Fluorodeoxyglucose Sales by Country (2018-2029)
3.7.3 Latin America Fluorodeoxyglucose Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fluorodeoxyglucose Market Facts & Figures by Country
3.8.1 Middle East and Africa Fluorodeoxyglucose Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Fluorodeoxyglucose Sales by Country (2018-2029)
3.8.3 Middle East and Africa Fluorodeoxyglucose Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fluorodeoxyglucose Sales by Type (2018-2029)
4.1.1 Global Fluorodeoxyglucose Sales by Type (2018-2023)
4.1.2 Global Fluorodeoxyglucose Sales by Type (2024-2029)
4.1.3 Global Fluorodeoxyglucose Sales Market Share by Type (2018-2029)
4.2 Global Fluorodeoxyglucose Revenue by Type (2018-2029)
4.2.1 Global Fluorodeoxyglucose Revenue by Type (2018-2023)
4.2.2 Global Fluorodeoxyglucose Revenue by Type (2024-2029)
4.2.3 Global Fluorodeoxyglucose Revenue Market Share by Type (2018-2029)
4.3 Global Fluorodeoxyglucose Price by Type (2018-2029)
5 Segment by Application
5.1 Global Fluorodeoxyglucose Sales by Application (2018-2029)
5.1.1 Global Fluorodeoxyglucose Sales by Application (2018-2023)
5.1.2 Global Fluorodeoxyglucose Sales by Application (2024-2029)
5.1.3 Global Fluorodeoxyglucose Sales Market Share by Application (2018-2029)
5.2 Global Fluorodeoxyglucose Revenue by Application (2018-2029)
5.2.1 Global Fluorodeoxyglucose Revenue by Application (2018-2023)
5.2.2 Global Fluorodeoxyglucose Revenue by Application (2024-2029)
5.2.3 Global Fluorodeoxyglucose Revenue Market Share by Application (2018-2029)
5.3 Global Fluorodeoxyglucose Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Md Anderson Cancer Center
6.1.1 Md Anderson Cancer Center Corporation Information
6.1.2 Md Anderson Cancer Center Description and Business Overview
6.1.3 Md Anderson Cancer Center Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Md Anderson Cancer Center Fluorodeoxyglucose Product Portfolio
6.1.5 Md Anderson Cancer Center Recent Developments/Updates
6.2 Shertech Laboratories, LLC
6.2.1 Shertech Laboratories, LLC Corporation Information
6.2.2 Shertech Laboratories, LLC Description and Business Overview
6.2.3 Shertech Laboratories, LLC Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shertech Laboratories, LLC Fluorodeoxyglucose Product Portfolio
6.2.5 Shertech Laboratories, LLC Recent Developments/Updates
6.3 Ucsf Radiopharmaceutical Facility
6.3.1 Ucsf Radiopharmaceutical Facility Corporation Information
6.3.2 Ucsf Radiopharmaceutical Facility Description and Business Overview
6.3.3 Ucsf Radiopharmaceutical Facility Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ucsf Radiopharmaceutical Facility Fluorodeoxyglucose Product Portfolio
6.3.5 Ucsf Radiopharmaceutical Facility Recent Developments/Updates
6.4 Memorial Sloan-kettering Cancer Center
6.4.1 Memorial Sloan-kettering Cancer Center Corporation Information
6.4.2 Memorial Sloan-kettering Cancer Center Description and Business Overview
6.4.3 Memorial Sloan-kettering Cancer Center Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Memorial Sloan-kettering Cancer Center Fluorodeoxyglucose Product Portfolio
6.4.5 Memorial Sloan-kettering Cancer Center Recent Developments/Updates
6.5 Hot Shots Nuclear Medicine Llc
6.5.1 Hot Shots Nuclear Medicine Llc Corporation Information
6.5.2 Hot Shots Nuclear Medicine Llc Description and Business Overview
6.5.3 Hot Shots Nuclear Medicine Llc Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hot Shots Nuclear Medicine Llc Fluorodeoxyglucose Product Portfolio
6.5.5 Hot Shots Nuclear Medicine Llc Recent Developments/Updates
6.6 Pharmalogic Holdings Corp
6.6.1 Pharmalogic Holdings Corp Corporation Information
6.6.2 Pharmalogic Holdings Corp Description and Business Overview
6.6.3 Pharmalogic Holdings Corp Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pharmalogic Holdings Corp Fluorodeoxyglucose Product Portfolio
6.6.5 Pharmalogic Holdings Corp Recent Developments/Updates
6.7 Nukemed Inc Dba Spectronrx
6.6.1 Nukemed Inc Dba Spectronrx Corporation Information
6.6.2 Nukemed Inc Dba Spectronrx Description and Business Overview
6.6.3 Nukemed Inc Dba Spectronrx Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nukemed Inc Dba Spectronrx Fluorodeoxyglucose Product Portfolio
6.7.5 Nukemed Inc Dba Spectronrx Recent Developments/Updates
6.8 Precision Nuclear Llc
6.8.1 Precision Nuclear Llc Corporation Information
6.8.2 Precision Nuclear Llc Description and Business Overview
6.8.3 Precision Nuclear Llc Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Precision Nuclear Llc Fluorodeoxyglucose Product Portfolio
6.8.5 Precision Nuclear Llc Recent Developments/Updates
6.9 The Methodist Hosp Research Institute
6.9.1 The Methodist Hosp Research Institute Corporation Information
6.9.2 The Methodist Hosp Research Institute Description and Business Overview
6.9.3 The Methodist Hosp Research Institute Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.9.4 The Methodist Hosp Research Institute Fluorodeoxyglucose Product Portfolio
6.9.5 The Methodist Hosp Research Institute Recent Developments/Updates
6.10 3d Imaging Drug Design And Development Llc
6.10.1 3d Imaging Drug Design And Development Llc Corporation Information
6.10.2 3d Imaging Drug Design And Development Llc Description and Business Overview
6.10.3 3d Imaging Drug Design And Development Llc Fluorodeoxyglucose Sales, Revenue and Gross Margin (2018-2023)
6.10.4 3d Imaging Drug Design And Development Llc Fluorodeoxyglucose Product Portfolio
6.10.5 3d Imaging Drug Design And Development Llc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fluorodeoxyglucose Industry Chain Analysis
7.2 Fluorodeoxyglucose Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fluorodeoxyglucose Production Mode & Process
7.4 Fluorodeoxyglucose Sales and Marketing
7.4.1 Fluorodeoxyglucose Sales Channels
7.4.2 Fluorodeoxyglucose Distributors
7.5 Fluorodeoxyglucose Customers
8 Fluorodeoxyglucose Market Dynamics
8.1 Fluorodeoxyglucose Industry Trends
8.2 Fluorodeoxyglucose Market Drivers
8.3 Fluorodeoxyglucose Market Challenges
8.4 Fluorodeoxyglucose Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Md Anderson Cancer Center
Shertech Laboratories, LLC
Ucsf Radiopharmaceutical Facility
Memorial Sloan-kettering Cancer Center
Hot Shots Nuclear Medicine Llc
Pharmalogic Holdings Corp
Nukemed Inc Dba Spectronrx
Precision Nuclear Llc
The Methodist Hosp Research Institute
3d Imaging Drug Design And Development Llc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂